Tivari Samir, Korah Reju, Lindy Michael, Wieder Robert
Department of Medicine and New Jersey Medical School Cancer Center, Rutgers New Jersey Medical School.
Department of Medicine and New Jersey Medical School Cancer Center, Rutgers New Jersey Medical School;
J Vis Exp. 2015 Jun 30(100):e52672. doi: 10.3791/52672.
The study of breast cancer dormancy in the bone marrow is an exceptionally difficult undertaking due to the complexity of the interactions of dormant cells with their microenvironment, their rarity and the overwhelming excess of hematopoietic cells. Towards this end, we developed an in vitro 2D clonogenic model of dormancy of estrogen-sensitive breast cancer cells in the bone marrow. The model consists of a few key elements necessary for dormancy. These include 1) the use of estrogen sensitive breast cancer cells, which are the type likely to remain dormant for extended periods, 2) incubation of cells at clonogenic density, where the structural interaction of each cell is primarily with the substratum, 3) fibronectin, a key structural element of the marrow and 4) FGF-2, a growth factor abundantly synthesized by bone marrow stromal cells and heavily deposited in the extracellular matrix. Cells incubated with FGF-2 form dormant clones after 6 days, which consist of 12 or less cells that have a distinct flat appearance, are significantly larger and more spread out than growing cells and have large cytoplasm to nucleus ratios. In contrast, cells incubated without FGF-2 form primarily growing colonies consisting of>30 relatively small cells. Perturbations of the system with antibodies, inhibitors, peptides or nucleic acids on day 3 after incubation can significantly affect various phenotypic and molecular aspects of the dormant cells at 6 days and can be used to assess the roles of membrane-localized or intracellular molecules, factors or signaling pathways on the dormant state or survival of dormant cells. While recognizing the in vitro nature of the assay, it can function as a highly useful tool to glean significant information about the molecular mechanisms necessary for establishment and survival of dormant cells. This data can be used to generate hypotheses to be tested in vivo models.
由于休眠细胞与其微环境相互作用的复杂性、其稀有性以及造血细胞的大量过剩,对骨髓中乳腺癌休眠的研究是一项极其困难的任务。为此,我们开发了一种体外二维克隆模型,用于研究雌激素敏感乳腺癌细胞在骨髓中的休眠。该模型由休眠所需的几个关键要素组成。这些要素包括:1)使用雌激素敏感乳腺癌细胞,这类细胞可能长时间保持休眠状态;2)以克隆密度培养细胞,此时每个细胞主要与基质发生结构相互作用;3)纤连蛋白,骨髓的关键结构成分;4)FGF-2,一种由骨髓基质细胞大量合成并大量沉积在细胞外基质中的生长因子。与FGF-2一起培养的细胞在6天后形成休眠克隆,这些克隆由12个或更少的细胞组成,具有独特的扁平外观,比生长中的细胞明显更大且更分散,并且细胞质与细胞核的比例很大。相比之下,未与FGF-2一起培养的细胞主要形成由>30个相对较小的细胞组成的生长菌落。在培养后第3天用抗体抑制剂、肽或核酸对该系统进行扰动,可显著影响6天时休眠细胞的各种表型和分子方面,并可用于评估膜定位或细胞内分子因子或信号通路对休眠状态或休眠细胞存活的作用。虽然认识到该检测方法的体外性质,但它可作为一种非常有用的工具,以收集有关休眠细胞建立和存活所需分子机制的重要信息。这些数据可用于生成有待在体内模型中测试的假设。